Cargando…

A novel TP53 pathway influences the HGS-mediated exosome formation in colorectal cancer

Tumor-derived exosomes are important for cell-cell communication. However, the role of TP53 in the control of exosome production in colorectal cancer (CRC) is controversial and unclear. The features of exosomes secreted from HCT116 TP53-wild type (WT), TP53-knockout (KO) and constructed TP53 (R273H)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yulin, Zheng, Weiwei, Guo, Zhengguang, Ju, Qiang, Zhu, Lin, Gao, Jiajia, Zhou, Lanping, Liu, Fang, Xu, Yang, Zhan, Qimin, Zhou, Zhixiang, Sun, Wei, Zhao, Xiaohang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911576/ https://www.ncbi.nlm.nih.gov/pubmed/27312428 http://dx.doi.org/10.1038/srep28083

Ejemplares similares

Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis
por: Ju, Qiang, et al.
Publicado: (2019)

Hgs Deficiency Caused Restrictive Cardiomyopathy via Disrupting Proteostasis
por: Li, Zhenhua, et al.
Publicado: (2022)

A novel rapid quantitative method reveals stathmin‐1 as a promising marker for esophageal squamous cell carcinoma
por: Yan, Lu, et al.
Publicado: (2018)

KRAS and TP53 Mutations in Colorectal Carcinoma
por: Al-Kuraya, Khawla S.
Publicado: (2009)

Smooth Muscle Hgs Deficiency Leads to Impaired Esophageal Motility
por: Chen, Jicheng, et al.
Publicado: (2015)

TP53 mutations in Romanian patients with colorectal cancer
por: Manirakiza, Felix, et al.
Publicado: (2023)

TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma
por: Li, Yong, et al.
Publicado: (2022)

HgsDb: Haplogroups Database to understand migration and molecular risk assessment
por: Arora, Devender, et al.
Publicado: (2015)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Histone Methyltransferase SETDB1 Promotes the Progression of Colorectal Cancer by Inhibiting the Expression of TP53
por: Chen, Keli, et al.
Publicado: (2017)

Noninvasive urinary protein signatures associated with colorectal cancer diagnosis and metastasis
por: Sun, Yulin, et al.
Publicado: (2022)

HgS Inhibits Oxidative Stress Caused by Hypoxia through Regulation of 5-HT Metabolism Pathway
por: He, Qiangqiang, et al.
Publicado: (2019)

TP53 loss creates therapeutic vulnerability in colorectal cancer
por: Liu, Yunhua, et al.
Publicado: (2015)

First-principles calculations of the II-VI semiconductor $\beta$-HgS: Metal or semiconductor
por: Delin, A
Publicado: (2002)

In-air Hand Gesture Signature Recognition: An iHGS Database Acquisition Protocol
por: Khoh, Wee How, et al.
Publicado: (2023)

Pro-Inflammatory Microenvironment Modulates the Transfer of Mutated TP53 Mediated by Tumor Exosomes
por: Domenis, Rossana, et al.
Publicado: (2021)

Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma
por: Kang, Nan, et al.
Publicado: (2018)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

A Prolyl-Hydroxylase Inhibitor, Ethyl-3,4-Dihydroxybenzoate, Induces Cell Autophagy and Apoptosis in Esophageal Squamous Cell Carcinoma Cells via Up-Regulation of BNIP3 and N-myc Downstream-Regulated Gene-1
por: Han, Bo, et al.
Publicado: (2014)

The impact of chemotherapeutic drugs on the CYP1A1-catalysed metabolism of the environmental carcinogen benzo[a]pyrene: Effects in human colorectal HCT116 TP53(+/+), TP53(+/−) and TP53(−/−) cells
por: Willis, Alexandra J., et al.
Publicado: (2018)

HGS-HIRe Lecture Week on Accelerator Physics & Technology: Intensity limitations in ion beams
por: Metral, Elias
Publicado: (2019)

Motor and Sensory Deficits in the teetering Mice Result from Mutation of the ESCRT Component HGS
por: Watson, Jennifer A., et al.
Publicado: (2015)

The Dual Role of an ESCRT-0 Component HGS in HBV Transcription and Naked Capsid Secretion
por: Chou, Shu-Fan, et al.
Publicado: (2015)

Association between targeted somatic mutation (TSM) signatures and HGS‐OvCa progression
por: Lindley, Robyn A., et al.
Publicado: (2016)

Clinical significance of p53 protein expression and TP53 variation status in colorectal cancer
por: Kim, Kyoung Min, et al.
Publicado: (2022)

Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer
por: Smeby, Jørgen, et al.
Publicado: (2019)

Receptor Interactive Protein Kinase 3 Promotes Cisplatin-Triggered Necrosis in Apoptosis-Resistant Esophageal Squamous Cell Carcinoma Cells
por: Xu, Yang, et al.
Publicado: (2014)

Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
por: Trauernicht, Max, et al.
Publicado: (2023)

High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer
por: Kim, Jeong Eun, et al.
Publicado: (2021)

TP53-inducible putative long noncoding RNAs encode functional polypeptides that suppress cell proliferation
por: Xu, Wenli, et al.
Publicado: (2022)

The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

ZnS, CdS and HgS Nanoparticles via Alkyl-Phenyl Dithiocarbamate Complexes as Single Source Precursors
por: Onwudiwe, Damian C., et al.
Publicado: (2011)

Utility of handgrip strength (HGS) and bioelectrical impedance analysis (BIA) in the diagnosis of sarcopenia in cirrhotic patients
por: Luengpradidgun, Lalida, et al.
Publicado: (2022)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015)

Disruption of tp53 leads to cutaneous nevus and melanoma formation in Xenopus tropicalis
por: Ran, Rensen, et al.
Publicado: (2022)

Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms
por: Moore, Ellen C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qhu3suidrrbastqebc4fvggch1